Pen Needles Market Report 2026 Market Outlook Supported By A Forecast 9.7% CAGR

The pen needles market is poised for significant expansion in the coming years, driven by evolving healthcare needs and technological advancements. As more patients and healthcare providers seek safer, more comfortable, and convenient injection options, the market is set to respond with innovative solutions and broader adoption across different therapies. Let's explore the current market size, key players, emerging trends, and detailed segmentation shaping the pen needles industry.

Forecasted Growth and Market Size of the Pen Needles Market
The pen needles market is projected to grow robustly, reaching a valuation of $4.34 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 9.7% during the forecast period. Several factors contribute to this expansion, including the increased use of GLP-1 therapies, heightened awareness and enforcement of needle safety regulations, a shift toward sustainable disposable medical products, rising demand for painless injection methods, and a growing preference for managing diseases at home. Key market trends anticipated over these years involve greater adoption of ultra-thin pen needles, a surge in demand for safety pen needle solutions, preference for shorter needle lengths, broadening of home-based injection therapies, and stronger emphasis on enhancing patient comfort and adherence.

Download a free sample of the Pen Needles market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15632&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Companies Driving the Pen Needles Market
The pen needles market features a range of prominent players that have established strong footholds globally. Notable companies include Cardinal Health Inc., Novo Nordisk AS, Becton dic*kinson and Company, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Artsana Group, Embecta Corp., Trividia Health Inc., Medical Technology and Devices S.p.A., Owen Mumford, Dynarex Corporation, UltiMed Inc., Bio-Med HealthCare Products Pvt. Ltd., Allison Medical Inc., GlucoRx Ltd., HTL-STREFA S.A., Hindustan Syringes and Medical Devices Ltd., Ypsomed AG, and Haselmeier GmbH.

A significant development occurred in August 2024 when Medical Technology and Devices S.p.A. (MTD), a manufacturer based in Italy, acquired Ypsomed's pen-needle and blood-glucose-monitoring (BGM) business. This move has increased MTD's total pen-needle production capability to over 2.5 billion units, reinforcing its status as a leading global pen needle supplier. Ypsomed Holding AG, headquartered in Switzerland, is well-regarded for its diabetes care technologies, particularly its range of injection and monitoring products.

View the full Pen Needles market report:
https://www.thebusinessresearchcompany.com/report/pen-needles-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends Highlighted by Innovation in Pen Needles
To improve patient experience and compliance, companies in the insulin pen-needle sector are focusing on the development of advanced designs, such as multi-bevel needles. These needles feature multiple precision-cut bevels at the tip, which make injections smoother and less painful. For example, in August 2025, Trividia Health Inc., a US-based diabetes care firm, launched its TRUEplus 5-Bevel Pen Needles in the UK market. These needles come in different gauges and lengths, including 31 G sizes of 5 mm, 6 mm, and 8 mm, as well as 32 G at 4 mm. They have a silicone coating to reduce friction, are sterile and single-use, and feature color-coded caps for easy size identification. Additionally, these 5-bevel needles are the most affordable prescription options available in the UK, offering a cost-effective alternative to traditional 3-bevel designs while prioritizing safety and comfort.

How the Pen Needles Market Is Structured and Segmented
This report breaks down the pen needles market into several key segments for better understanding:
1) By Type: Standard Pen Needles and Safety Pen Needles
2) By Needle Length: Short Length, Medium Length, and Long Length Pen Needles
3) By Therapy: Insulin, Glucagon-like Peptide-1 (GLP-1), and Growth Hormone
4) By Mode of Purchase: Retail and Non-Retail
5) By End User: Hospitals and Clinics, Home Healthcare, and Other End Users

Further subcategories include:
- For Standard Pen Needles: Fixed-Needle, Removable-Needle, Short Pen Needles (4 mm, 5 mm), and Long Pen Needles (8 mm, 12 mm)
- For Safety Pen Needles: Automatic Safety Pen Needles, Manual Safety Pen Needles, Retractable Safety Pen Needles, and Shielded Safety Pen Needles

This detailed segmentation helps provide a clear picture of the various product offerings, user preferences, and therapeutic applications that characterize the pen needles market today and into the near future.

What's new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.